These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12575360)

  • 1. [Changes of cardiac inside diameter and ejection fraction in patients with heart failure after the treatment with nitroprusside].
    Qian ZX; Sun M; Chen YM
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):183-4. PubMed ID: 12575360
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator therapy for decompensated heart failure.
    Yancy CW
    J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilator therapy in cardiac failure what was new is old.
    O'Rourke MF; Nichols WW
    J Am Coll Cardiol; 2009 Mar; 53(10):898; discussion 898-99. PubMed ID: 19264253
    [No Abstract]   [Full Text] [Related]  

  • 7. [Administration of nitroprusside in the therapy of refractory cardiac failure (author's transl)].
    Nikolić V; Sjerobabski V; Barić L; Pilas V; Planinc D; Vukosavić D
    Lijec Vjesn; 1981 Nov; 103(11):495-500. PubMed ID: 7343794
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with preserved ejection fraction in older adults.
    Chen MA
    Am J Med; 2009 Aug; 122(8):713-23. PubMed ID: 19635270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic indices of patients with acute left-ventricular failure being treated with sodium nitroprusside].
    Tatishvili NI; Chkhaidze ZK; Kurashvili RB; Mamatsashvili MD; Narsiia NN
    Ter Arkh; 1984; 56(4):112-5. PubMed ID: 6729714
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
    Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.
    Cingolani HE; Plastino JA; Escudero EM; Mangal B; Brown J; Pérez NG
    J Card Fail; 2006 Sep; 12(7):491-8. PubMed ID: 16952781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial structure and function differ in systolic and diastolic heart failure.
    van Heerebeek L; Borbély A; Niessen HW; Bronzwaer JG; van der Velden J; Stienen GJ; Linke WA; Laarman GJ; Paulus WJ
    Circulation; 2006 Apr; 113(16):1966-73. PubMed ID: 16618817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP correlates not only with ejection fraction, but also with inferior vena cava diameter in patients with acute heart failure.
    Pudil R; Tichy M; Blaha V; Praus R; Vojacek J
    Clin Chim Acta; 2007 Mar; 378(1-2):230. PubMed ID: 17182022
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.